Showing results (1511-1520 of 1,886) with videos related to

Sort By:
Pageof 189
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Cancer|December 15, 2020
Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neckMoran Amit, Chuan Liu, Frederico O Gleber-Netto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in MelanomaAdil I Daud, Jedd D Wolchok, Caroline Robert, et al.
Journal of Translational Medicine|July 28, 2023
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2018
Combined BRAF and HSP90 Inhibition in Patients with Unresectable <i>BRAF</i> <sup>V600E</sup>-Mutant MelanomaZeynep Eroglu, Y Ann Chen, Geoffrey T Gibney, et al.
Head & Neck|July 29, 2016
Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approachesClifton D Fuller, Abdallah S R Mohamed, Adam S Garden, et al.
The Journal of Biological Chemistry|October 31, 2000
A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejectionR Horuk, C Clayberger, A M Krensky, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT InhibitionRichard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Pageof 189